Literature DB >> 16263055

Central nervous system Lyme disease.

John J Halperin1.   

Abstract

Nervous system infection with Borrelia burgdorferi frequently causes meningitis and rarely causes encephalomyelitis. Altered cognitive function also can occur in the absence of central nervous system infection. Recently developed serodiagnostic tools, such as the C6 assay, and appropriate use of Western blotting promise to improve diagnostic accuracy. Treatment trials have demonstrated the efficacy of relatively brief courses of oral antimicrobial agents, even in peripheral nervous system infection and meningitis. Several well-performed studies have clearly shown that prolonged antimicrobial treatment of "post-Lyme disease" is ineffective. Diagnosis and treatment of Lyme disease continue to improve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263055     DOI: 10.1007/s11910-005-0032-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  30 in total

1.  Treatment of Lyme disease.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2000-05-01       Impact factor: 1.909

2.  Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis.

Authors:  L Dotevall; L Hagberg
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease.

Authors:  J D England; R P Bohm; E D Roberts; M T Philipp
Journal:  Ann Neurol       Date:  1997-03       Impact factor: 10.422

4.  Lyme neuroborreliosis. Peripheral nervous system manifestations.

Authors:  J Halperin; B J Luft; D J Volkman; R J Dattwyler
Journal:  Brain       Date:  1990-08       Impact factor: 13.501

5.  Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.

Authors:  M Karlsson; S Hammers-Berggren; L Lindquist; G Stiernstedt; B Svenungsson
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

6.  Long-term follow-up of patients with culture-confirmed Lyme disease.

Authors:  John Nowakowski; Robert B Nadelman; Rebecca Sell; Donna McKenna; L Frank Cavaliere; Diane Holmgren; Adriana Gaidici; Gary P Wormser
Journal:  Am J Med       Date:  2003-08-01       Impact factor: 4.965

7.  Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria.

Authors:  E E Smouha; P K Coyle; S Shukri
Journal:  Am J Otol       Date:  1997-03

8.  Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.

Authors:  R J Dattwyler; J J Halperin; D J Volkman; B J Luft
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

Review 9.  Nervous system Lyme disease.

Authors:  John J Halperin
Journal:  Vector Borne Zoonotic Dis       Date:  2002       Impact factor: 2.133

Review 10.  Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease.

Authors:  Mark S Klempner
Journal:  Vector Borne Zoonotic Dis       Date:  2002       Impact factor: 2.133

View more
  2 in total

1.  Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Authors:  Jan D Lünemann; Harald Gelderblom; Mireia Sospedra; Jacqueline A Quandt; Clemencia Pinilla; Adriana Marques; Roland Martin
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

2.  Immunogenetic Markers Definition in Latvian Patients with Lyme Borreliosis and Lyme Neuroborreliosis.

Authors:  Lilija Kovalchuka; Svetlana Cvetkova; Julija Trofimova; Jelena Eglite; Sandra Gintere; Irina Lucenko; Barbara Oczko-Grzesik; Ludmila Viksna; Angelika Krumina
Journal:  Int J Environ Res Public Health       Date:  2016-12-01       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.